期刊档案
ImmunoAnalysis
ISSN 2783-2589 · Tabriz University of Medical Sciences · Iran, Islamic Republic of
ImmunoAnalysis 钻石开放获取（无 APC），免版面费，投稿社区反馈审稿约 8 周，2025 年发文 1 篇。
研究范围
研究范围与定位
ImmunoAnalysis 由 Tabriz University of Medical Sciences 出版。按 OpenAlex 近年发文统计，该刊主要发表 Electrochemical sensors and biosensors、Cancer Immunotherapy and Biomarkers、Immunotherapy and Immune Responses 等主题的论文，这 3 个主题约占 19.3%。（根据 OpenAlex 主题统计与中科院分区数据生成）
ImmunoAnalysis is a peer-reviewed multidisciplinary open access journal, covering a wide range of various integrative fields with immunoanalysis. The main aims of this journal are to publish up-to-date articles in the field of immunoanalysis, expansion and development of knowledge in the fields of pharmaceutical analysis and immunology and other related fields, actively working towards addressing the world's scientific and research demands in the immunoanalysis sector, and facilitating the sharing of new research insights in immunoanalysis, thereby expanding the horizons of human knowledge. ImmunoAnalysis encourages submission of manuscripts related to developing bioanalysis methods such as quantification of small molecules, peptides, proteins, antibodies biomarkers and immunoassay methods, and studies in immunology field such as innate immunity and inflammation; development; immune receptors, cellular and systemic immunity; vaccines; immune tolerance; autoimmunity and tumor immunology, microbial immunopathology, novel or improved cutting-edge analytical platforms, methods and sensors for rapid and accurate measurement of pharmaceutical, biomedical, or natural products. Research Areas Include: • Immunoassay methods • Analytical approaches for omics development • Biosensor and pharmaceutical analysis • Bioanalysis and bioactivity assays • Biomarker’s analysis • Extraction and purification of immune drugs • Immunology • Tumor markers • Immuno and cheminformatics • Tumor immunology • Immunopharmacology
摘自期刊官网 Aims & Scope
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Electrochemical sensors and biosensorsEngineering7.2%
- Cancer Immunotherapy and BiomarkersMedicine6%
- Immunotherapy and Immune ResponsesImmunology and Microbiology6%
- Chronic Lymphocytic Leukemia ResearchMedicine6%
- vaccines and immunoinformatics approachesBiochemistry, Genetics and Molecular Biology6%
- COVID-19 Clinical Research StudiesMedicine4.8%
- SARS-CoV-2 and COVID-19 ResearchMedicine4.8%
- Analytical chemistry methods developmentChemistry4.8%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）未收录
该期刊未被此版本分区表收录。
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 6OpenAlex ·
- i10-index
- 2OpenAlex ·
- 两年平均被引
- 0.62OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 52 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 0 | 0 | 16 |
| 2025 | 1 | 1 | 37 |
| 2024 | 12 | 12 | 30 |
| 2023 | 13 | 13 | 15 |
| 2022 | 14 | 14 | 7 |
| 2021 | 12 | 12 | 3 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
样本不足近 24 个月只有 3 篇文章登记了投稿与接收日期，不足以给出中位数
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 8 WeeksLetPub ·
- 投稿到发表（期刊自报）
- 约 8 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
钻石开放获取（无 APC）DOAJ
所有文章开放获取，且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 无文章处理费 | — | — |
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点3 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- ≥ 3 个
- 投稿信（Cover letter）
- 必须提供
接收的文章类型5 种
- editorialEditorial: The Journal’s editors write the editorial.未说明篇幅
- letterLetter: Comments or concerns on specific subjects; overall or pertaining to items published in the journal. Also, new or additional findings of original nature.未说明篇幅
- research articleResearch article: Original work resulting from research, constituting complete studies that contain all relevant information. Including systematic review and me…未说明篇幅
- reviewReview: Narrative reviews on clinically relevant topics.未说明篇幅
- short communicationShort communication: Original work, but less substantial than the regular research article, presenting preliminary results, or results of immediate relevance.未说明篇幅
官网政策摘录作者资格、数据可用性、许可与版权、同行评审、查重
- 作者资格 Author Contribution
Authors should provide the information related to the Authors' Contribution section (CRediT) when submitting the article. If the Authors’ Contribution section is not sent at the time of submitting the article, it must be submitted when sending the corrections requested by the reviewers. The corresponding author is responsible for the accuracy and validity of the information. The Authors' Contribut…
原文 ↗出版商官网 ·- 数据可用性 Data Sharing
Data sharing encouraged. 模型摘要
ImmunoAnalysis encourages authors to share the data and any other material associated with methodology and the results of the submitted articles, in an appropriate public repository, or as open access supplementary to the article. In line with ICMJE recommendations, a data sharing statement is required for manuscripts reporting the results of clinical trials, on whether and how the data will be av…
原文 ↗出版商官网 ·- 许可与版权
CC-BY 4.0 license; authors retain copyright. 模型摘要
The authors retain the copyright to their work without restrictions, licensing under the Creative Commons license 4.0 (CC-BY).
原文 ↗出版商官网 ·- 同行评审
Double-blind peer review process. 模型摘要
Since all papers will undergo a double-blind peer review process
原文 ↗出版商官网 ·- 查重
iThenticate software used for plagiarism checking. 模型摘要
We use iThenticate software in the processing of the submissions.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Tabriz University of Medical Sciences
- 出版国家或地区
- Iran, Islamic Republic of
- 出版语言
- English
- ISSN
- 2783-2589
- 学会 / 主办单位
- Pharmaceutical Analysis Research Center
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
- 查重政策 ↗DOAJ
常见问题
关于 ImmunoAnalysis 的常见问题
ImmunoAnalysis 的审稿周期多长？
投稿社区反馈的平均审稿速度为约 8 周。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
ImmunoAnalysis 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：≥ 3 个；投稿信：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
ImmunoAnalysis 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，ImmunoAnalysis 被 DOAJ 收录。
ImmunoAnalysis 是开放获取期刊吗？版面费多少？
ImmunoAnalysis 为钻石开放获取（无 APC）。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。